Literature DB >> 23304363

Evaluation of automated term groupings for detecting anaphylactic shock signals for drugs.

Julien Souvignet1, Gunnar Declerck, Béatrice Trombert, Jean Marie Rodrigues, Marie-Christine Jaulent, Cédric Bousquet.   

Abstract

Signal detection in pharmacovigilance should take into account all terms related to a medical concept rather than a single term. We built an OWL-DL file with formal definitions of MedDRA and SNOMED-CT concepts and performed two queries, Query 1 and 2, to retrieve narrow and broad terms within the Standard MedDRA Query (SMQ) related to 'anaphylactic shock' and the terms from the High Level Term (HLT) grouping related to 'anaphylaxis'. We compared values of the EB05 (EBGM) statistical test for disproportionality with 50 active ingredients randomly selected in the public version of the FDA pharmacovigilance database. Coefficient of correlation was R(2) = 1.00 between Query 1 and HLT; R(2) = 0.98 between Query 1 and SMQ narrow; R(2) = 0.89 between Query 2 and SMQ Narrow+Broad. Generating automated groupings of terms for signal detection is feasible but requires additional efforts in modeling MedDRA terms in order to improve precision and recall of these groupings.

Entities:  

Mesh:

Year:  2012        PMID: 23304363      PMCID: PMC3540466     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  15 in total

1.  Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.

Authors:  S J Evans; P C Waller; S Davis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2001 Oct-Nov       Impact factor: 2.890

2.  Responding to drug safety issues.

Authors:  P C Waller; E H Lee
Journal:  Pharmacoepidemiol Drug Saf       Date:  1999-12       Impact factor: 2.890

3.  Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance.

Authors:  Corneliu Henegar; Cédric Bousquet; Agnès Lillo-Le Louët; Patrice Degoulet; Marie-Christine Jaulent
Journal:  Comput Biol Med       Date:  2005-09-26       Impact factor: 4.589

4.  Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions.

Authors:  Cédric Bousquet; Georges Lagier; Agnès Lillo-Le Louët; Christine Le Beller; Alain Venot; Marie-Christine Jaulent
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  What counts in data mining?

Authors:  Manfred Hauben; Vaishali K Patadia; David Goldsmith
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

6.  PharmARTS: terminology web services for drug safety data coding and retrieval.

Authors:  Iulian Alecu; Cédric Bousquet; Patrice Degoulet; Marie-Christine Jaulent
Journal:  Stud Health Technol Inform       Date:  2007

Review 7.  Principles of signal detection in pharmacovigilance.

Authors:  R H Meyboom; A C Egberts; I R Edwards; Y A Hekster; F H de Koning; F W Gribnau
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606

8.  A Bayesian neural network method for adverse drug reaction signal generation.

Authors:  A Bate; M Lindquist; I R Edwards; S Olsson; R Orre; A Lansner; R M De Freitas
Journal:  Eur J Clin Pharmacol       Date:  1998-06       Impact factor: 2.953

9.  Adverse drug reactions: finding the needle in the haystack.

Authors:  I R Edwards
Journal:  BMJ       Date:  1997-08-30

10.  Adverse event profiles of 5-fluorouracil and capecitabine: data mining of the public version of the FDA Adverse Event Reporting System, AERS, and reproducibility of clinical observations.

Authors:  Kaori Kadoyama; Ikuya Miki; Takao Tamura; J B Brown; Toshiyuki Sakaeda; Yasushi Okuno
Journal:  Int J Med Sci       Date:  2011-11-17       Impact factor: 3.738

View more
  2 in total

1.  Patterns of use and impact of standardised MedDRA query analyses on the safety evaluation and review of new drug and biologics license applications.

Authors:  Lin-Chau Chang; Riaz Mahmood; Samina Qureshi; Christopher D Breder
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

2.  Good Signal Detection Practices: Evidence from IMI PROTECT.

Authors:  Antoni F Z Wisniewski; Andrew Bate; Cedric Bousquet; Andreas Brueckner; Gianmario Candore; Kristina Juhlin; Miguel A Macia-Martinez; Katrin Manlik; Naashika Quarcoo; Suzie Seabroke; Jim Slattery; Harry Southworth; Bharat Thakrar; Phil Tregunno; Lionel Van Holle; Michael Kayser; G Niklas Norén
Journal:  Drug Saf       Date:  2016-06       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.